KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cme (CME) Net Margin (2016 - 2025)

Historic Net Margin for Cme (CME) over the last 17 years, with Q3 2025 value amounting to 58.31%.

  • Cme's Net Margin rose 14300.0% to 58.31% in Q3 2025 from the same period last year, while for Sep 2025 it was 58.1%, marking a year-over-year increase of 14800.0%. This contributed to the annual value of 56.79% for FY2024, which is 3100.0% down from last year.
  • As of Q3 2025, Cme's Net Margin stood at 58.31%, which was up 14300.0% from 59.82% recorded in Q2 2025.
  • Over the past 5 years, Cme's Net Margin peaked at 83.48% during Q3 2021, and registered a low of 43.28% during Q2 2021.
  • Moreover, its 5-year median value for Net Margin was 56.45% (2023), whereas its average is 56.22%.
  • As far as peak fluctuations go, Cme's Net Margin skyrocketed by 454000bps in 2021, and later plummeted by -288200bps in 2022.
  • Quarter analysis of 5 years shows Cme's Net Margin stood at 52.81% in 2021, then fell by -1bps to 52.16% in 2022, then rose by 7bps to 55.88% in 2023, then rose by 1bps to 56.62% in 2024, then grew by 3bps to 58.31% in 2025.
  • Its Net Margin stands at 58.31% for Q3 2025, versus 59.82% for Q2 2025 and 57.49% for Q1 2025.